Seguir
Ornella Corazza
Ornella Corazza
Professor of Addiction Science, School of Life and Medical Sciences, University of Hertfordshire
Dirección de correo verificada de herts.ac.uk
Título
Citado por
Citado por
Año
Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance
O Király, MN Potenza, DJ Stein, DL King, DC Hodgins, JB Saunders, ...
Comprehensive psychiatry 100, 152180, 2020
9382020
Mephedrone, new kid for the chop?
AR Winstock, LR Mitcheson, P Deluca, Z Davey, O Corazza, F Schifano
Addiction 106 (1), 154-161, 2011
4262011
Mephedrone (4-methylmethcathinone;‘meow meow’): chemical, pharmacological and clinical issues
F Schifano, A Albanese, S Fergus, JL Stair, P Deluca, O Corazza, Z Davey, ...
Psychopharmacology 214, 593-602, 2011
3602011
Manifesto for a European research network into problematic usage of the internet
NA Fineberg, Z Demetrovics, DJ Stein, K Ioannidis, MN Potenza, ...
European Neuropsychopharmacology 28 (11), 1232-1246, 2018
3102018
Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project
P Deluca, Z Davey, O Corazza, L Di Furia, M Farre, LH Flesland, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 39 (2), 221-226, 2012
2492012
Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a …
E Cinosi, G Martinotti, P Simonato, D Singh, Z Demetrovics, ...
BioMed research international 2015 (1), 968786, 2015
2332015
Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data
F Schifano, S D’Offizi, M Piccione, O Corazza, P Deluca, Z Davey, ...
Psychotherapy and psychosomatics 80 (2), 118-122, 2011
2252011
Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine
O Corazza, F Schifano, P Simonato, S Fergus, S Assi, J Stair, J Corkery, ...
Human Psychopharmacology: Clinical and Experimental 27 (2), 145-149, 2012
1752012
e-Psychonauts: conducting research in online drug forum communities
Z Davey, F Schifano, O Corazza, P Deluca, ...
Journal of Mental Health 21 (4), 386-394, 2012
1712012
Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project
O Corazza, S Assi, P Simonato, J Corkery, FS Bersani, Z Demetrovics, ...
Human Psychopharmacology: Clinical and Experimental 28 (4), 317-323, 2013
1612013
From “Special K” to “Special M”: the evolution of the recreational use of ketamine and methoxetamine
O Corazza, S Assi, F Schifano
CNS neuroscience & therapeutics 19 (6), 454-460, 2013
1452013
The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study
O Corazza, P Simonato, Z Demetrovics, R Mooney, K Van De Ven, ...
PloS one 14 (4), e0213060, 2019
1252019
25C‐NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug
FS Bersani, O Corazza, G Albano, G Valeriani, R Santacroce, ...
BioMed research international 2014 (1), 734749, 2014
1192014
Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1, 4-butanediol (1, 4-BD; BDO): a literature review with a focus on UK fatalities related to non-medical use
JM Corkery, B Loi, H Claridge, C Goodair, O Corazza, S Elliott, F Schifano
Neuroscience & Biobehavioral Reviews 53, 52-78, 2015
1072015
Designer drugs on the internet: a phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly
O Corazza, F Schifano, M Farre, P Deluca, Z Davey, C Drummond, ...
Current clinical pharmacology 6 (2), 125-129, 2011
1072011
Psychoactive drug or mystical incense? Overview of the online available information on Spice products
F Schifano, O Corazza, P Deluca, Z Davey, L Di Furia, M Farre', ...
International Journal of Culture and Mental Health 2 (2), 137-144, 2009
1072009
Problematic use of the internet during the COVID-19 pandemic: Good practices and mental health recommendations
B Gjoneska, MN Potenza, J Jones, O Corazza, N Hall, CMD Sales, ...
Comprehensive psychiatry 112, 152279, 2022
992022
“Spice,”“kryptonite,”“black mamba”: an overview of brand names and marketing strategies of novel psychoactive substances on the web
O Corazza, G Valeriani, FS Bersani, J Corkery, G Martinotti, G Bersani, ...
Journal of Psychoactive Drugs 46 (4), 287-294, 2014
992014
‘Legal highs’ an inappropriate term for ‘Novel Psychoactive Drugs’ in drug prevention and scientific debate
O Corazza, Z Demetrovics, W van den Brink, F Schifano
International Journal of Drug Policy 24 (1), 82-83, 2013
972013
Sexual Enhancement Products for Sale Online: Raising Awareness of the Psychoactive Effects of Yohimbine, Maca, Horny Goat Weed, and Ginkgo biloba
O Corazza, G Martinotti, R Santacroce, E Chillemi, M Di Giannantonio, ...
BioMed research international 2014 (1), 841798, 2014
942014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20